Directed Differentiation of Human Induced Pluripotent Stem Cells into Dendritic Cells Displaying Tolerogenic Properties and Resembling the CD141(+) Subset

The advent of induced pluripotent stem cells (iPSCs) has begun to revolutionize cell therapy by providing a convenient source of rare cell types not normally available from patients in sufficient numbers for therapeutic purposes. In particular, the development of protocols for the differentiation of...

Descripción completa

Detalles Bibliográficos
Autores principales: Sachamitr, Patty, Leishman, Alison J., Davies, Timothy J., Fairchild, Paul J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5766641/
https://www.ncbi.nlm.nih.gov/pubmed/29358940
http://dx.doi.org/10.3389/fimmu.2017.01935

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5766641/
https://www.ncbi.nlm.nih.gov/pubmed/29358940
http://dx.doi.org/10.3389/fimmu.2017.01935

Ejemplares similares